Samsara BioCapital GP, LLC

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Samsara BioCapital GP, LLC's trades of Mineralys Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-17 2025-03-13
B Purchase
62,946 +27.3%
290.45
US$3,067,657 		62,946 +27.3% 290.45 US$3,067,657
2024-11-27 2024-11-26
US Neurogene Inc (NGNE)
B Purchase
15,715 -5.6%
155.34
US$327,713 		15,715 -5.6% 155.34 US$327,713
2024-11-27 2024-11-26
US Neurogene Inc (NGNE)
B Purchase
29,906 +40.7%
10.23
US$1,044,147 		29,906 +40.7% 10.23 US$1,044,147
2024-11-27 2024-11-26
US Neurogene Inc (NGNE)
B Purchase
10,803 +0.6%
26.01
US$280,986 		10,803 +0.6% 26.01 US$280,986
2024-11-27 2024-11-26
US Neurogene Inc (NGNE)
B Purchase
20,748 +1.2%
24.91
US$516,833 		20,748 +1.2% 24.91 US$516,833
2024-06-03 2024-05-30
B Purchase
294,000 +7.1%
17.00
US$4,998,000 		294,000 +7.1% 17.00 US$4,998,000
2024-02-14 2024-02-12
B Purchase
555,555 +12.3%
13.50
US$7,499,992 		555,555 +12.3% 13.50 US$7,499,992
2023-11-16 2023-11-14
B Purchase
666,666 +19.3%
15.00
US$9,999,990 		666,666 +19.3% 15.00 US$9,999,990
2023-10-18 2023-10-16
B Purchase
2,189,781 +47.6%
6.85
US$15,000,000 		2,189,781 +47.6% 6.85 US$15,000,000